General communications

14.01.2022

Reports of suspected adverse reactions to COVID-19 vaccines

11,467 reports of suspected adverse vaccination reactions evaluated

01.01.2022

Changes to the guidance document Project Orbis HMV4

Change in procedure for Project Orbis: Swissmedic information requests now to be sent exclusively to the applicant in Switzerland

01.01.2022

Changes to the guidance document Temporary authorisation of human medicinal products HMV4

Simplification of the procedure for “ex officio" temporary authorisation

17.12.2021

Reports of suspected adverse reactions to COVID-19 vaccines

10,842 reports of suspected adverse vaccination reactions evaluated

17.12.2021

ICH and IPRP meetings – Swissmedic has ICH Assembly Vice-Chair once more

Swissmedic supports the ICH’s ongoing development into a global initiative

16.12.2021

Easier access to the Electronic Vigilance Reporting Portal (ElViS) for pharmacists via hp-id

Healthcare professionals can now use their Healthcare Professional Identity (hp-id) to access ElViS

14.12.2021

Access Consortium statement on COVID-19 medicines

The Consortium’s medicines regulators will only authorize medicines for COVID-19 if their clinical benefits outweigh their risks.

13.12.2021

Update – Warning about supposedly herbal products

Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products

10.12.2021

Swissmedic approves COVID-19 vaccine from Pfizer/BioNTech for children aged 5 to 11 years

Comirnaty® approved for children aged 5 years and older – roughly a year after the initial authorisation for adults

06.12.2021

New psychoactive substances

12 individual substances and one substance group added to the Narcotics List

02.12.2021

Ten years of the Medicrime Convention

Ten years ago, Switzerland was one of the first states to sign the Medicrime Convention.

02.12.2021

Aufsichtsabgabe 2021 – Selbstdeklaration

Eingabefrist: 21. Januar 2022

26.11.2021

Reports of suspected adverse reactions to COVID-19 vaccines

10,386 reports of suspected adverse vaccination reactions evaluated

24.11.2021

New member of the Agency Council of Swissmedic

The seven-strong Agency Council is Swissmedic's supervisory body

05.11.2021

Reports of suspected adverse reactions to COVID-19 vaccines

9,834 reports of suspected adverse vaccination reactions evaluated

01.11.2021

New guidance document: Involvement of patient organisation in assessment of patient information HMV4

The new guidance document is valid with effect from 1 November 2021.

19.10.2021

CureVac withdraws authorisation application for COVID-19 vaccine

Vaccine candidate CVnCoV no longer in rolling review procedure

Last modification 19.04.2021

Top of page